FIELD: medicine.
SUBSTANCE: invention concerns medical products and concerns a pharmaceutical composition in the form of a solution for local application at treatment of the dermatological diseases chosen from psoriasis, atopic eczema, contact dermatitis, including in a pharmaceutically comprehensible medium of a) 0.0003% of calcitriol, and b) >0.001% - 0.05% of clobetasol propionate. Application of the composition for reception of a medicinal product and for treatment of dermatological diseases is also revealed. The compositions, under the invention, provide greater efficiency, than the ointment containing the same quantities of the components a) and b).
EFFECT: provision of greater efficiency, than the ointment containing the same quantities of components.
9 cl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AEROSOL COMPOSITION CONTAINING COMBINATION OF CLOBETASOL PROPIONATE AND CALCITRIOL, ALCOHOLIC PHASE AND OIL PHASE | 2005 |
|
RU2384337C2 |
| COMPOSITIONS CONTAINING CROMOGLYCIC ACID FOR TREATMENT OF DERMATITIS | 2017 |
|
RU2754006C2 |
| METHOD FOR TREATING DISEASES AND CONDITIONS OF THE EYE | 2012 |
|
RU2667645C1 |
| USE OF PLANT EXTRACT AS ACTIVE AGENT IN TREATMENT OF DERMATOLOGICAL DISEASES | 2018 |
|
RU2782197C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND CONDITIONS CONTAINING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDROQUINOLINE | 2012 |
|
RU2630978C2 |
| COMPOUND OF AVERMECTIN FAMILY OR OF MILBEMYCIN FAMILY FOR TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | 2014 |
|
RU2669942C1 |
| COENZYME Q-CONTAINING CUTANEOUS COMPOSITIONS AS ACTIVE COMPONENT | 2001 |
|
RU2283098C2 |
| THERAPEUTIC AGENT FOR INHIBITION OF PHOSPHODIESTERASE AND ASSOCIATED PATHOLOGICAL DISORDERS | 2018 |
|
RU2815010C2 |
| AVERMECTIN OR MILBEMYCIN FAMILY COMPOUND FOR TREATMENT AND/OR PREVENTION OF ADOPIC DERMATITIS | 2014 |
|
RU2792693C2 |
| OINTMENT COMPOSITION CONTAINING VITAMIN D DERIVATIVE | 2007 |
|
RU2448713C2 |
